YZi Labs discussed opportunities at the intersection of artificial intelligence, biotechnology, and blockchain at Hong Kong FinTech Week. YZi Labs posted on X.

The discussion highlighted longevity research, where AI can help speed up work involving models, biomarkers, and treatments, potentially supporting more individualized care. It also explored an agent-driven economy, in which blockchain could facilitate continuous peer-to-peer payments without intermediaries at every step.

YZi Labs said medical and biological data remain isolated across hospitals and laboratories, limiting their use in training and safe sharing. It pointed to cryptography as a way to let models draw insights while protecting personal privacy.

The firm said it evaluates product retention, durable competitive advantages, and founders’ commitment to the problems they address. It also described efforts to apply AI across research, sourcing, due diligence, and portfolio support.